TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Main Feed
Today's Market Intel
Stock Reports
AI Research Reports
Top Stocks
AI-Curated Stock Lists
Commentary
Opinionated Stock Takes
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
IPO Calendar
Upcoming Listings
CommunityDashboard
Log inCreate Account
← Back to TickerSpark
▌Earnings Flash·August 10, 2026

Hims & Hers Health, Inc. (HIMS) drops after earnings misses

Hims & Hers Health, Inc. (HIMS) drops 5.5% as the company reports earnings misses, pressuring shares in early trading and weighing on investor sentiment.

Earnings FlashHIMSHealthcareMedical - Equipment & Services
By TickerSpark·August 10, 2026·2 min read
Hims & Hers Health, Inc. (HIMS) drops after earnings misses
▌Key Takeaway
Hims & Hers Health, Inc. (HIMS) reported a mixed quarter, missing earnings per share at -$0.10 versus expectations of -$0.04979 while beating revenue at $0.75 billion versus $0.70 billion. Shares fell 5.48% to $29.86 in after-hours trading as investors prioritized the wider-than-expected loss over the sales beat. The key takeaway for investors is that HIMS still needs to convert strong revenue growth into consistent profitability.

Hims & Hers Health (HIMS) earnings miss, stock drops

Hims & Hers Health, Inc. (HIMS) missed on EPS at -$0.10 versus -$0.04979 expected but beat revenue at $0.75B versus $0.70B, sending shares down 5.48% to $29.86 in after-hours trading.

Key Numbers

  • EPS: -$0.10 actual versus -$0.04979 estimate, a miss.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

Revenue: $0.75B actual versus $0.70B estimate, a beat.
  • After-hours price: $29.86, down 5.48% from the $31.59 regular-session close.
  • EPS trend: HIMS posted losses of -$0.10 and -$0.40 in its latest two quarters, after positive EPS of $0.07, $0.06, and $0.17.
  • After-hours session volume reached 16,101,097 shares versus an average of 18,391,998.

    • Revenue Beat Fails to Translate Into Profit

    The split result is the central story. HIMS beat its revenue estimate, but its per-share loss came in worse than expected. Sales growth did not translate into bottom-line earnings this quarter.

    The latest loss follows a -$0.40 EPS result in May, marking two straight quarterly losses after three profitable quarters. The earnings call should be judged against one concrete issue: whether the revenue beat can translate into positive EPS after this reversal.

    The 5.48% after-hours decline shows traders focused on earnings quality rather than revenue alone. For a growth stock, that is a costly distinction.

    Bottom line: HIMS delivered a revenue beat, but the EPS miss and second straight quarterly loss make profitability the stock's immediate hurdle.

    Read the full HIMS research report
    ▌Common Questions

    Frequently asked questions

    +Why did Hims & Hers stock drop after earnings?
    Hims & Hers Health, Inc. (HIMS) fell 5.48% after hours because it missed EPS expectations, reporting a loss of -$0.10 versus the -$0.04979 estimate. Although revenue beat estimates at $0.75 billion versus $0.70 billion, traders focused on the weaker-than-expected bottom line.
    +Did Hims & Hers beat revenue in the latest quarter?
    Yes, Hims & Hers Health, Inc. (HIMS) reported revenue of $0.75 billion, above the $0.70 billion consensus estimate. The revenue beat was not enough to offset the earnings miss, however, and the stock sold off after hours.
    +How bad was the EPS miss for HIMS?
    Hims & Hers Health, Inc. (HIMS) posted EPS of -$0.10 compared with expectations for a -$0.04979 loss. That means the company lost more per share than analysts had projected, extending a run of two straight quarterly losses.
    +What does the latest HIMS earnings report mean for investors?
    The report shows that Hims & Hers Health, Inc. (HIMS) can still grow revenue, but profitability remains the immediate challenge. Investors will likely want to see whether future sales growth can translate into positive EPS after two consecutive quarters of losses.
    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌The Full Report

    Want the full picture on HIMS?

    The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.

    Read the HIMS report →Get Full Access →

    Not ready to subscribe? ·

    ▌The Full Report

    Get the full HIMS research report

    • Analyst-grade deep dive
    • Charts, valuation, grades
    • Buy/sell price targets
    Read the HIMS report →
    ▌For Active Investors

    Smarter research, on every ticker

    • Daily market intelligence
    • On-demand stock analysis
    • AI analyst chat
    Get Full Access →

    Cancel anytime

    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, free in your inbox.

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌More on HIMS

    More to read

    All articles
    Hims & Hers Health (HIMS): Weight-Loss Growth vs. Execution Risk
    HIMS

    Hims & Hers Health (HIMS): Weight-Loss Growth vs. Execution Risk

    Hims & Hers Health is building a large consumer health platform, but recent growth and earnings pressure make the stock a Hold. International expansion and branded GLP-1 access could reaccelerate results, yet valuation already reflects much of the upside.

    Aug 11·20 min
    Hims & Hers Health, Inc. (HIMS) gains on deep earnings analysis
    HIMS

    Hims & Hers Health, Inc. (HIMS) gains on deep earnings analysis

    Hims & Hers Health, Inc. (HIMS) gained despite an EPS miss, as revenue beat estimates and growth momentum stayed intact. This deep-dive examines the mixed print, profitability pressure, Wegovy demand, analyst sentiment, and whether the stock’s gains are supported by fundamentals.

    Aug 11·6 min
    Tempus AI (TEM): Growth Is Real, Profitability Isn’t Yet
    TEM

    Tempus AI (TEM): Growth Is Real, Profitability Isn’t Yet

    Tempus AI is scaling quickly in oncology diagnostics and data licensing, but losses, negative free cash flow, and leverage keep the stock in Hold territory.

    Aug 20·19 min